Tests a device treatment for newly diagnosed open angle glaucoma
Studies whether a laser device lowers eye pressure in people newly diagnosed with glaucoma.
Plain-language title generated from the registry record
Registry title: DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
Key facts
- Where
- Mesa, United StatesSee the site
Where in United States
- Barnet Dulaney Perkins Eye CentersMesa, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Barnet Dulaney Perkins Eye Centers
- Trial code
- NCT06933836
- Record updated
- 18 April 2025
- Original description
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.Read full original descriptionShow less
How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Inclusion: Primary open angle glaucoma; Patients age 30 or greater with an IOP of 18-26 mmHg; Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines); DSLT procedure.
Exclusion: History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery; Ocular Hypertension; Uncontrolled systemic microvascular disease (eg. HTN, DM); Angle closure patients; Baseline VF MD of worse than -12dB; Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium).